Autoimmunity: regulatory B cells--IL-35 and IL-21 regulate the regulators

Area of Science:

• Immunology
• Autoimmune Diseases
• Cell Biology

Background:

• Interleukin-21 (IL-21) is known to regulate the activity and number of interleukin-10-producing regulatory B cells (B10 cells).
• B10 cells play a crucial role in modulating immune responses and preventing autoimmune conditions.
• Dysregulation of B10 cells is implicated in the pathogenesis of various autoimmune diseases.

Purpose of the Study:

• To investigate the role of Interleukin-35 (IL-35) in regulating B10 cell function.
• To identify potential regulatory circuits controlling B10 cell activity in vivo.
• To explore the therapeutic potential of targeting these regulatory mechanisms for autoimmune diseases.

Main Methods:

• In vivo studies to assess the effects of IL-35 on B10 cell populations.
• Flow cytometry and cytokine analysis to quantify B10 cell activity and function.
• Investigation of signaling pathways involved in IL-35-mediated B10 cell regulation.

Main Results:

• The study demonstrates that IL-35 exhibits a function similar to IL-21 in regulating B10 cells.
• IL-35 influences both the number and activity of B10 cells.
• Evidence suggests IL-35 contributes to the immune-regulatory functions of B10 cells.

Conclusions:

• IL-35 is identified as a key regulator of B10 cells, alongside IL-21.
• Understanding the regulatory circuits governing B10 cells, particularly those involving IL-35, is critical.
• Targeting these regulatory pathways offers a promising avenue for developing novel treatments for autoimmune diseases.